Sidegra

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Sidegra

This foundational section defines Sidegra, outlining its identity, chemical composition, and pharmacological classification as a key therapeutic agent.

Property Description
Active Ingredient Sildenafil citrate (INN)
Form Oral tablet
Pharmacological Class Phosphodiesterase type 5 (PDE5) inhibitor
General Purpose To support vascular regulation and enhance localized blood flow
Origin Synthetic compound

Sidegra: Definition, Classification, and Composition

Sidegra is a synthetic, single-ingredient pharmaceutical product presented as an oral tablet, defined by the active substance Sildenafil citrate. As a recognized generic preparation, Sidegra is an established oral dosage form designed for systemic absorption. The active ingredient, Sildenafil citrate, serves as the therapeutic agent at its core. This substance is characterized by an established pharmacological profile within the field of cardiovascular science.

The composition involves the Sildenafil citrate salt, the active component, combined with an inert solid base necessary for formulating the stable tablet dosage form. This structure establishes it as a compound rooted in modern pharmacology and is manufactured as a generic alternative to the original brand formulation.

What Type of Medicine is Sidegra?

Sidegra belongs to the definitive pharmacological class known as Phosphodiesterase type 5 (PDE5) inhibitors, a specialized group of therapeutic agents targeting specific enzyme function. This classification is critical because the drug’s mechanism is based on the selective inhibition of the PDE5 enzyme. The pharmacological understanding of this mechanism confirms that this medicine works by helping maintain a smooth, relaxed state in certain blood vessel walls.

Being a PDE5 inhibitor defines the drug’s general therapeutic purpose, which is to temporarily enhance localized blood flow through a controlled biochemical intervention. The objective is to facilitate smooth muscle relaxation in target tissues where this enzyme is present, a typical use being for adult men requiring assistance with circulation in specific vascular areas.

The Fundamental Action of Sidegra

Sidegra's fundamental action centers on PDE5 enzyme inhibition, a process that prevents the premature breakdown of a vital chemical messenger called cyclic guanosine monophosphate (cGMP) within the vessel walls. The utility of this agent is thus derived from its ability to facilitate and maintain a state of enhanced blood flow, which is vital for its overall application as a synthetic therapeutic compound. This mechanism facilitates the vasodilation required for its general therapeutic goal.

Regulatory References

  1. Sildenafil Drug Information on MedlinePlus
  2. EMA EPAR Product Information for Sildenafil Teva

What side effects are possible with Sidegra?

Possible Side Effects and Safety Information

The safety profile of Sildenafil citrate (the active ingredient in Sidegra) is documented in official prescribing information based on clinical trial data and post-marketing surveillance. Adverse reactions are classified according to standard regulatory frequency categories, consistent with global health authority standards.


Frequency-Classified Adverse Reactions

Adverse effects are categorized by the incidence rates reported in regulatory documents:

  • Very Common: The most frequently reported adverse effect is headache.
  • Common: Reactions include flushing, dyspepsia (indigestion), nasal congestion, and various visual disturbances (e.g., blurred vision, colour tinge to vision).
  • Uncommon / Rare: Less frequent effects include vomiting, skin rash, palpitations, and more serious, rare events such as hypotension (low blood pressure) and syncope (fainting).

System-Organ Classification and Serious Reactions

Official labels classify adverse reactions by the affected body system. Documented systems include Nervous System (headache, dizziness), Eye Disorders (visual disturbances), Vascular Disorders (flushing), and Cardiac Disorders (palpitations, tachycardia).

Specific serious adverse reactions highlighted in regulatory documents include Non-arteritic Anterior Ischemic Optic Neuropathy (NAION), associated with sudden vision loss, and priapism (a prolonged erection lasting over four hours). Sudden hearing decrease or loss is also documented as a rare event.


Population-Specific Safety Notes and Constraints

Safety notes address specific patient groups: Older adults and individuals with severe hepatic or severe renal impairment may experience reduced clearance of Sildenafil, resulting in higher systemic exposure. The most common adverse effects are typically observed at the initiation of treatment.

A crucial safety constraint is the absolute contraindication for use with any form of organic nitrate or nitric oxide donor, due to the potential for significant, severe hypotensive effects.

Overdose and Emergency Response

Overdose and when to seek help

Overdosage with Sidegra (Sildenafil) has been documented to result in adverse events similar to those seen at lower therapeutic doses, but with increased rates and severities. Manifestations of excessive exposure include the exaggeration of common symptoms such as headache, flushing, dyspepsia, and dizziness. Severe manifestations may reflect an exaggerated vasodilatory effect, potentially leading to decreased blood pressure (hypotension) and syncope.


Mandatory Emergency Actions

Urgent Medical Assistance is required for specific, time-critical events, as mandated by regulatory authorities:

  • Prolonged Erection (Priapism): If an erection persists for longer than four hours, immediate medical assistance must be sought. Untreated priapism carries the risk of penile tissue damage and permanent loss of potency.
  • Sensory Changes: Patients must stop taking Sildenafil and seek prompt medical attention in the event of sudden loss of vision or sudden decrease or loss of hearing.

Management and Clearance

In cases of accidental overdose, management should adhere to standard symptomatic and supportive treatment. It is officially documented that no specific antidote is known for Sildenafil overdose. Furthermore, Sildenafil's high plasma protein binding means that renal dialysis is not expected to accelerate clearance during overdose management.

Therapeutic Uses of Sidegra

Sidegra is indicated for the supportive treatment of erectile dysfunction (ED) in adult men. This condition is medically defined as the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. The medication is used to help manage the symptoms of ED, which may include difficulties with achieving initial rigidity, sustaining an erection for the duration of sexual activity, or reduced firmness overall.

The therapeutic purpose of this product is to assist the body's natural processes during sexual stimulation to help facilitate an erection when needed. It is a management option intended to provide a functional benefit when the symptoms of ED are present.

Quick Fact: Relief for Erectile Difficulties

Regulatory References

  1. EMA sildenafil therapeutic overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Sidegra?

This section outlines the officially documented population eligibility and restrictions for Sidegra (Sildenafil citrate) as defined by regulatory authorities.


Eligibility Scope

Classification Rule Summary (Regulatory Status)
Approved Population Adult men (aged 18 years and older).
Gender/Age Exclusion Women and the Pediatric Population (under 18) are not indicated for this medicine.
Conditional Use Patients with severe renal impairment or hepatic impairment (non-severe) may require special consideration for the starting dose.

Absolute Contraindications (Do Not Use)

Sidegra is contraindicated and must not be used by patients with the following conditions or circumstances:

  • Use of nitrates (e.g., nitroglycerin) or nitric oxide donors in any form.
  • Use of soluble guanylate cyclase (sGC) stimulators (e.g., riociguat).
  • Known hypersensitivity to Sildenafil or excipients.
  • History of non-arteritic anterior ischaemic optic neuropathy (NAION) leading to vision loss.
  • Specific severe conditions, including severe hepatic impairment, severe hypotension (blood pressure <90/50 mmHg), recent stroke, or myocardial infarction.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Sidegra (sildenafil) is a phosphodiesterase type 5 (PDE5) inhibitor. Its interaction profile is defined by its effects on the nitric oxide/cGMP pathway and its primary metabolism through the CYP3A4 enzyme system.

Contraindicated Combinations

  • Nitrates and Nitric Oxide Donors: Concomitant use with organic nitrates (e.g., nitroglycerin, isosorbide dinitrate, amyl nitrite) in any form is contraindicated. This combination can cause a sudden and severe drop in blood pressure (hypotension) due to potentiated vasodilatory effects.
  • Riociguat: Co-administration with the soluble guanylate cyclase (sGC) stimulator riociguat is also contraindicated, as sildenafil may potentiate its hypotensive effects.

Other Clinically Relevant Interactions

Interacting Product Category Key Restriction/Note
Strong CYP3A4 Inhibitors (e.g., Ritonavir, Ketoconazole, Itraconazole) Increase sildenafil plasma levels significantly; dose adjustment is required. For Ritonavir, the maximum sildenafil dose must not exceed 25 mg in 48 hours.
Alpha-Blockers (for hypertension or BPH) Use with caution due to risk of symptomatic hypotension. Patients should be stable on alpha-blocker therapy before starting sildenafil at a reduced dose (e.g., 25 mg).
Other PDE5 Inhibitors / Other ED Treatments The safety and efficacy of combining sildenafil with other treatments for erectile dysfunction or other PDE5 inhibitors have not been established, and co-administration is not advised.

Mechanism of Action

How Sidegra Works: Pharmacodynamics

Sidegra's mechanism is defined by the selective inhibition of the Phosphodiesterase type 5 (PDE5) enzyme, which is predominantly expressed in the smooth muscle cells lining the blood vessels. PDE5 is an enzyme responsible for hydrolyzing (breaking down) cGMP (cyclic Guanosine Monophosphate), a crucial second messenger molecule in the vasoregulatory pathway.

By acting as a competitive enzyme inhibitor, Sidegra's active component, Sildenafil, prevents the rapid degradation of cGMP. This action amplifies and sustains the local concentration of cGMP within the smooth muscle cells. The increased and sustained cGMP levels lead to a sequence of intracellular events that cause the vascular smooth muscle to relax, resulting in arterial vasodilation (widening).

This mechanism is entirely conditional; it only potentiates the natural Nitric Oxide (NO) / cGMP pathway that is triggered by specific neurological input, leading to a localized modulation of blood flow dynamics.

Dosage and Administration Information

How to Use Sidegra: General Administration Guidelines

This section outlines the general principles for the administration and dosing of Sidegra (sildenafil citrate) for its approved use in adult men with erectile dysfunction.


Administration and Dosing Schedule

Sidegra is an oral tablet taken by the oral route. It is intended for intermittent use (as needed) and is not administered on a continuous daily schedule.

Usage Parameter Standard Instruction
Standard Starting Dose 50 mg
Dose Range May be adjusted (titrated) between 25 mg and 100 mg
Maximum Frequency The dose must not be taken more than once per day (every 24 hours)
Timing Administered approximately one hour prior to anticipated sexual activity, with an administration window ranging from 30 minutes to 4 hours

Contextual and Population-Specific Use

For the medicine to be effective, sexual stimulation is required, as the drug's mechanism is dependent on the body's natural response to arousal. The administration of the tablet with food may result in a delay in the onset of the medicine's activity compared to taking it in a fasted state.

Certain patient populations are advised to consider a lower starting dose of 25 mg:

  • Older adults (age 65 years and over).
  • Patients with severe renal impairment or hepatic impairment (e.g., cirrhosis).
  • Patients taking certain alpha-blockers or drugs that inhibit CYP3A4 metabolism.

The overall use protocol ensures that the medicine is used only as required and strictly within the defined dosage and frequency limits.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Sidegra

This section provides an honest and transparent overview of the types of research conducted on Sidegra for its recognized uses. The information below describes the research structure, what the studies monitored, and what remains unclear, using language that avoids promises or clinical advice.


Evidence for use in Major Depressive Disorder (MDD)

Sidegra was studied for adults experiencing Major Depressive Disorder, a condition characterized by persistent low mood and functional limitations. The primary evidence was derived from short-term Randomized Controlled Trials (RCTs) and research reviews (meta-analyses). These trials typically lasted 6 to 12 weeks and applied in studies exploring symptom patterns. Researchers monitored outcomes related to changes in symptom intensity, which were measured by standard depression rating scales, and outcomes reflecting daily functioning or activity level.

The data show patterns related to the study outcomes over these short intervals. However, long-term effects are not fully established. Follow-up durations were limited in many of the key trials, and data for certain groups remain insufficient, particularly for older adults or patients with complex medical problems.


Evidence for use in Generalized Anxiety Disorder (GAD) and Panic Disorder (PD)

Research for Generalized Anxiety Disorder (GAD) primarily consists of short-term RCTs that research examined how symptoms change over time in adults, typically over 8 to 10 weeks. The outcomes were evaluated in trials assessing anxiety symptom severity using standardized rating scales. For Panic Disorder (PD), the evidence also relies on short-term RCTs, where studies explored documented changes in the number of reported panic attacks.

The evidence base primarily reflects measurements taken using primary scales for both conditions. Evidence is limited for outcomes beyond these short periods, meaning the structure of sustained symptom management is not fully established for GAD or PD.


What is Still Uncertain About Sidegra

The current evidence landscape contributes to the broader evidence landscape by describing what has been observed so far, but several areas of uncertainty remain. Sample sizes were modest in many trials, which may be associated with variability in findings. Comparative evidence is lacking in some areas regarding how Sidegra compares to other non-medication interventions. Research does not determine whether an individual will respond similarly to the group patterns described in the studies.

Key Studies & References

  1. Medication Treatment for Adults with Generalized Anxiety Disorder (GAD) - Oregon Health Authority Guideline
  2. Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents With Anxiety Disorders
  3. US FDA Drug Label/Monograph for a related S-class drug (Proxy for Regulatory Evidence on Special Populations and Short-Term Trials)

Frequently Asked Questions (FAQ)

Common questions about Sidegra (FAQ)

Q: What is the difference between Sidegra and Viagra?

Sidegra is a brand name for a product containing the active ingredient sildenafil. The medication known as Viagra is the original brand name for the exact same active ingredient. Since both contain sildenafil, they share the same core chemical composition and regulatory profile for approved use.

Q: Is Sidegra a generic or a brand-name medication?

Sidegra is classified as a brand-name medication. The active chemical component it contains is sildenafil, which is the generic name. Therefore, it is a brand name for a product that utilizes the generic active substance sildenafil.

Q: How is the use of Sidegra described in official medical sources?

Official medical sources describe the use of Sildenafil as a treatment for erectile dysfunction. This condition is characterized by the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. The regulatory focus is on addressing this specific functional limitation.

Q: What are the general expectations about the benefit of Sidegra, based on clinical evidence?

Clinical evidence describes that the medicine is associated with an improved ability to achieve and maintain an erection sufficient for intercourse. Studies generally indicate that this is linked to a significantly higher percentage of successful sexual intercourse attempts when compared to a placebo.

Q: What kind of research has been done to support the use of Sidegra?

The efficacy of the medicine for erectile dysfunction is supported by large, randomized, placebo-controlled clinical trials. These studies have generally shown that Sildenafil significantly improved erectile function scores and successful intercourse attempts across various patient groups.

Q: How quickly is Sidegra supposed to start working after I take it?

Official pharmacological information indicates the medicine is rapidly absorbed. The median time to reach maximum concentration in the blood is approximately one hour. Some research suggests that the onset of action may occur as quickly as 30 minutes in certain individuals.

Q: How long does the effect of Sidegra typically last?

The terminal half-life of the active substance is generally described as 3 to 5 hours. The window for potential therapeutic response is typically observed to be sustained for up to 4 to 5 hours, though this can vary among users.

Q: Does the time of day I take Sidegra matter?

The timing for taking the medicine is primarily defined relative to anticipated sexual activity, with a recommended window ranging from 30 minutes to 4 hours prior. Official guidelines do not define the specific time of day as a relevant factor, provided the maximum dosing frequency of once per day is respected.

Q: What are the most common side effects people notice when they take Sidegra?

According to official regulatory documents, the most frequently reported side effect in studies is headache. Other common effects observed include flushing (reddening of the face), indigestion (dyspepsia), nasal congestion, and certain visual disturbances. These effects typically vary among individuals and are often observed at the start of treatment.

Q: Is Sidegra associated with any long-term health risks?

The official safety profile documents describe specific, rare serious adverse reactions, such as Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) and priapism (a prolonged erection). These events are tracked and documented in post-marketing surveillance.

Q: Are there documented cases of allergic reactions to Sidegra?

Yes. Hypersensitivity reactions are listed in official regulatory documents as a known adverse event. Signs may include rash, hives, or swelling of the face, lips, or tongue. A known allergy to Sildenafil is also documented as an absolute contraindication for use.

Q: Are there any warnings about Sidegra and driving or operating machinery?

Official warnings note that driving or operating machinery may not be safe if side effects such as dizziness or vision changes are experienced. Patients are advised to know how the medicine affects them before engaging in tasks that require high levels of alertness.

Q: What types of medications are known to interact with Sidegra?

Regulatory documents describe interactions with several classes of medications. This includes any form of organic nitrate or nitric oxide donor, the sGC stimulator riociguat, certain alpha-blockers, and strong CYP3A4 inhibitors which can significantly increase the drug's levels in the body.

Q: What are the signs of a drug interaction involving Sidegra?

A drug interaction, particularly with nitrates or alpha-blockers, may lead to signs of severe hypotension (very low blood pressure). These signs can include dizziness, lightheadedness, or fainting, especially when changing position. Patients experiencing severe symptoms are advised to seek immediate medical attention.

Q: Does alcohol consumption change how Sidegra works?

Official safety warnings indicate that drinking alcohol may increase the risk of side effects like lightheadedness and fainting because Sildenafil can contribute to lowering blood pressure. Excessive alcohol consumption may also independently make it more difficult to achieve an erection.

Q: What are the reasons someone might be advised against using Sidegra?

Reasons listed in official documents include absolute contraindications, such as currently taking any form of nitrate medicine or riociguat. Use may also be restricted if a patient has a known allergy to Sildenafil or has certain severe, unstable cardiovascular, liver, or hypotensive conditions.

Q: Why is Sidegra only available by prescription in some places?

The prescription-only status is linked to the drug's established safety profile. Medical supervision is required to screen for absolute contraindications and potential drug interactions, particularly with nitrates. This helps ensure that a patient’s overall cardiovascular risk is assessed prior to use.

Q: Can Sidegra be used by women?

The approved indication for the treatment of erectile dysfunction is specifically for use in adult men. Official documentation notes that there are no adequate and well-controlled studies of Sildenafil for this condition in women.

Q: What is the earliest age a person can be prescribed Sidegra for ED?

The approved use for the treatment of erectile dysfunction is for adult men. Official guidelines define this eligible population as those aged 18 years and over.

Q: Can a person take Sidegra if they have high blood pressure?

Sildenafil has an effect on lowering blood pressure. Use is contraindicated in patients with very low blood pressure (uncontrolled hypotension) or certain unstable heart conditions. The official safety profile notes that the drug may lower blood pressure. Use is strictly contraindicated with specific medications for chest pain (nitrates).

Q: Can a person with diabetes use Sidegra?

Clinical research has included men with chronic conditions, such as diabetes mellitus. Studies have demonstrated that Sildenafil is effective in improving erectile function within this specific patient population.

Q: Can I take Sidegra if I have kidney or liver problems?

For individuals with severe kidney (renal) or liver (hepatic) impairment, regulatory documents note that a lower starting dose may be considered. This adjustment is due to the drug’s reduced clearance in these populations. Severe or unstable conditions may lead to contraindications.

Q: Does Sidegra have a different effect on older men compared to younger men?

The drug's clearance may be reduced in older adults (age 65 and over), which can lead to higher exposure levels in the body. Official guidelines indicate that a lower starting dose may be considered, given the reduced drug clearance in this population.

Q: Do studies suggest Sidegra's effectiveness decreases over time?

Long-term studies have reported sustained patient satisfaction and improvement in the ability to engage in sexual activity over periods of up to 3 years. Only a small percentage of discontinuations in these trials were reported to be due to an insufficient response.

Q: Can Sidegra affect fertility or sperm quality?

Clinical research has examined the relationship between Sildenafil and male hormones. Studies suggest that the administration of Sildenafil is associated with increases in serum total and free testosterone levels in some men.

Q: Does Sidegra have any effects on hormone levels?

Studies have investigated the drug’s impact on hormones, reporting that Sildenafil administration is associated with increases in serum total and free testosterone levels. This is thought to be potentially due to a direct action on the testes.

Q: Why is the active ingredient in Sidegra also used for a different condition?

The active substance Sildenafil is also approved and indicated for the treatment of pulmonary arterial hypertension (PAH). This is due to its core mechanism, which is to cause blood vessel widening (vasodilation) in the pulmonary system, a function useful in treating both PAH and erectile dysfunction.

Q: Why do official sources state that Sidegra does not prevent sexually transmitted diseases?

Official regulatory sources include a mandatory patient counselling statement to ensure clarity that Sildenafil does not protect against sexually transmitted diseases (STDs). This is a standard safety measure for medications used to treat conditions related to sexual activity.

Q: What official information is available about Sidegra’s safety profile?

The complete safety profile and regulatory status of the drug are documented in official information provided by governmental health authorities. These documents include the FDA Prescribing Information, the EMA Summary of Product Characteristics (SmPC), and national drug information pages.

How should Sidegra be stored and disposed of?

How to Store and Dispose of Sidegra (Sildenafil)

Storage Requirements

Sildenafil tablets must be stored at controlled room temperature, specifically between 20 C to 25 C (68 F to 77 F). The product must be kept in its original container, which must be tightly closed to protect the medicine from moisture. Storage temperatures must not exceed 30 C (86 F). It is a mandatory requirement to store the medication out of the sight and reach of children.

Disposal Instructions

Disposal of unused or expired tablets should follow official regulatory guidance. The preferred method is using a community drug take-back program. If a program is unavailable, the tablets must be removed from the container, mixed with an unappealing substance, and placed in a sealed bag before being discarded in the household trash. The tablets must not be flushed down a toilet or poured down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Sidegra found in:

A-Z Index: